Abstract |
Hypoxia inducible factor (HIF) is important in cancer, as it regulates various oncogenic genes as well as genes involved in cell survival, proliferation, and migration. Elevated HIF-1 protein promotes a more aggressive tumor phenotype, and greater HIF-1 expression has been demonstrated to correlate with poorer prognosis, increased risk of metastasis and increased mortality. Recent reports suggest that HIF-1 activates autophagy, a lysosomal degradation pathway which may promote tumor cell survival. We show here that HIF-1α expression is constitutively active in multiple diffuse large B cell lymphoma (DLBCL) cell lines under normoxia and it is regulated by the PI3K/AKT pathway. PCI-24781, a pan histone deacetylase inhibitor (HDACI), enhanced accumulation of HIF-1α and induced autophagy initially, while extended incubation with the drug resulted in inhibition of HIF-1α. We tested the hypothesis that PCI-24781- induced autophagy is mediated by HIF-1α and that inhibition of HIF-1α in these cells results in attenuation of autophagy and decreased survival. We also provide evidence that autophagy serves as a survival pathway in DLBCL cells treated with PCI-24781 which suggests that the use of autophagy inhibitors such as chloroquine or 3-methyl adenine in combination with PCI-24781 may enhance apoptosis in lymphoma cells.
|
Authors | Savita Bhalla, Andrew M Evens, Sheila Prachand, Paul T Schumacker, Leo I Gordon |
Journal | PloS one
(PLoS One)
Vol. 8
Issue 11
Pg. e81333
( 2013)
ISSN: 1932-6203 [Electronic] United States |
PMID | 24312289
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Benzofurans
- HIF1A protein, human
- Histone Deacetylase Inhibitors
- Hydroxamic Acids
- Hypoxia-Inducible Factor 1, alpha Subunit
- Phosphatidylinositol 3-Kinases
- Proto-Oncogene Proteins c-akt
- AMP-Activated Protein Kinases
- abexinostat
|
Topics |
- AMP-Activated Protein Kinases
(metabolism)
- Autophagy
(drug effects)
- Benzofurans
(pharmacology)
- Cell Survival
(drug effects)
- Drug Synergism
- Enzyme Activation
(drug effects)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Histone Deacetylase Inhibitors
(pharmacology)
- Humans
- Hydroxamic Acids
(pharmacology)
- Hypoxia-Inducible Factor 1, alpha Subunit
(metabolism)
- Lymphoma, Large B-Cell, Diffuse
(pathology)
- Phosphatidylinositol 3-Kinases
(metabolism)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Signal Transduction
(drug effects)
|